| Year |
Citation |
Score |
| 2017 |
Kosowicz JG, Lee J, Peiffer B, Guo Z, Chen J, Liao G, Hayward SD, Liu JO, Ambinder RF. Drug modulators of B cell signaling pathways and Epstein-Barr virus lytic activation. Journal of Virology. PMID 28566383 DOI: 10.1128/Jvi.00747-17 |
0.509 |
|
| 2015 |
Lee HG, Kim H, Kim EJ, Park PG, Dong SM, Choi TH, Kim H, Chong CR, Liu JO, Chen J, Ambinder RF, Hayward SD, Park JH, Lee JM. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation. Oncotarget. PMID 26427042 DOI: 10.18632/Oncotarget.5041 |
0.51 |
|
| 2011 |
Shirley CM, Chen J, Shamay M, Li H, Zahnow CA, Hayward SD, Ambinder RF. Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. Blood. 117: 6297-303. PMID 21447826 DOI: 10.1182/Blood-2011-01-332379 |
0.628 |
|
| 2008 |
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nature Medicine. 14: 1118-22. PMID 18776891 DOI: 10.1038/Nm.1864 |
0.641 |
|
| 2007 |
Fu DX, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, Chong JM, Ambinder RF, Pomper MG. Virus-associated tumor imaging by induction of viral gene expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1453-8. PMID 17332288 DOI: 10.1158/1078-0432.Ccr-06-2295 |
0.654 |
|
| Show low-probability matches. |